Risk factors of diffuse alveolar hemorrhage after acute ischemic stroke treated with tissue-type plasminogen activator. The effectiveness of activated recombinant factor VII treatment

BACKGROUND: Diffuse alveolar hemorrhage (DAH) is a rare and frequently life-threatening complication of a variety of conditions. DAH may result from coagulation disorders, inhaled toxins, or infections. We report a series of patients who developed DAH after receiving a tissue-type plasminogen activa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Yu, Tsuchiya, Katsuhiro, Fujisawa, Norihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294161/
https://www.ncbi.nlm.nih.gov/pubmed/32547816
http://dx.doi.org/10.25259/SNI_2_2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294161/
https://www.ncbi.nlm.nih.gov/pubmed/32547816
http://dx.doi.org/10.25259/SNI_2_2020

Ejemplares similares